Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
THE YAG LASER AND WALLSTENT ENDOPROSTHESIS FOR PALLIATION OF CANCER IN THE ESOPHAGUS OR GASTRIC CARDIA
Autore:
TRANBERG KG; VONHOLSTEIN CS; IVANCEV K; CWIKIEL W; LUNDERQUIST A;
Indirizzi:
LUND UNIV,DEPT SURG S-22185 LUND SWEDEN LUND UNIV,DEPT DIAGNOST RADIOL S-22185 LUND SWEDEN
Titolo Testata:
Hepato-gastroenterology
fascicolo: 2, volume: 42, anno: 1995,
pagine: 139 - 144
SICI:
0172-6390(1995)42:2<139:TYLAWE>2.0.ZU;2-S
Fonte:
ISI
Lingua:
ENG
Soggetto:
MALIGNANT DYSPHAGIA; ENDOSCOPIC INTUBATION; RANDOMIZED TRIAL; THERAPY; LIMITATIONS; OBSTRUCTION; STRICTURES; CARCINOMA; STENTS;
Keywords:
ESOPHAGUS; NEOPLASMS; LASER THERAPY; ENDOPROSTHESIS; SELF-EXPANDING METALLIC STENT;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
21
Recensione:
Indirizzi per estratti:
Citazione:
K.G. Tranberg et al., "THE YAG LASER AND WALLSTENT ENDOPROSTHESIS FOR PALLIATION OF CANCER IN THE ESOPHAGUS OR GASTRIC CARDIA", Hepato-gastroenterology, 42(2), 1995, pp. 139-144

Abstract

The need for frequent retreatment is a disadvantage of using endoscopic laser therapy (ELT) alone for palliative treatment of esophageal carcinoma. In this prospective study, therefore, we investigated the potential and feasibility of combining ELT with a self-expanding metallicstent (Wallstent). Twelve patients received ELT followed by stent placement (stent group) and were compared with 39 patients receiving ELT alone (ELT group). Swallowing ability was similar in the two groups. About one-third of the patients who had a short life expectancy, did not appear to benefit from stenting, whereas the interval between retreatments was prolonged by a factor of 2-4 in the remaining patients. Median survivals were 5.5 (range 1.0-23.5) months in patients with stents, and 4.5 (range 1.2-24.6) months in patients without stents. There were few complications related to stenting. In one patient, technical problems caused stent dislodgement into the stomach. Another stent patient died of hemorrhage from an untreated tumor in the stomach, but it was considered unlikely that the bleeding was caused by the stent. In conclusion, this preliminary trial suggests that a Wallstent endoprosthesis, used in combination with laser treatment, may become a valuable tool for prolonging the dysphagia-free interval in selected patients.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/07/20 alle ore 05:33:53